Literature DB >> 13129852

Low endogenous glucocorticoid allows induction of kidney cortical cyclooxygenase-2 during postnatal rat development.

Kirsten Madsen1, Jane Stubbe, Tianxin Yang, Ole Skøtt, Sebastian Bachmann, Boye L Jensen.   

Abstract

In postnatal weeks 2-4, cyclooxygenase-2 (COX-2) is induced in the rat kidney cortex where it is critically involved in final stages of kidney development. We examined whether changes in circulating gluco- or mineralocorticosteroids or in their renal receptors regulate postnatal COX-2 induction. Plasma corticosterone concentration peaked at birth, decreased to low levels at days 3-13, and increased to adult levels from day 22. Aldosterone peaked at birth and then stabilized at adult levels. Gluco- and mineralocorticoid receptor (GR and MR) mRNAs were expressed stably in kidney before, during, and after COX-2 induction. 11 beta-hydroxysteroid dehydrogenase 2 was induced shortly after birth and was widely distributed in the whole collecting duct system in the suckling period and then returned to an adult pattern. Supplementation with corticosterone (20 mg.kg-1.day-1) or GR-specific dexamethasone (1 mg.kg-1.day-1) during low endogenous corticosterone suppressed renal COX-2 mRNA and protein and led to a restricted distribution of COX-2 immunolabeling. The ability of glucocorticoids to affect COX-2 was reflected in colocalization of GR-alpha and COX-2 immunoreactivity and mRNAs in thick ascending limb of Henle's loop. The MR antagonist potassium canrenoate (20 mg.kg-1.day-1) enhanced COX-2 expression from days 5 to 10, but low MR-specific concentrations of DOCA (1 mg.kg-1.day-1) had no effect on COX-2. Renomedullary interstitial cells expressed GR-alpha and COX-2. Dexamethasone suppressed COX-2 in these cells. Thus low plasma concentrations of corticosterone allowed for cortical and medullary COX-2 induction during postnatal kidney development. Increased circulating glucocorticoid in the postnatal period may damage late renal development through inhibition of COX-2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129852     DOI: 10.1152/ajprenal.00099.2003

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  6 in total

1.  Renal and endocrine changes in rats with inherited stress-induced arterial hypertension (ISIAH).

Authors:  Sergej Amstislavsky; Pia Welker; Jan-Henning Frühauf; Larissa Maslova; Ludmila Ivanova; Boye Jensen; Arkady L Markel; Sebastian Bachmann
Journal:  Histochem Cell Biol       Date:  2005-12-08       Impact factor: 4.304

2.  Prostaglandin E2 EP3 receptor regulates cyclooxygenase-2 expression in the kidney.

Authors:  Carlos P Vio; Mariana Quiroz-Munoz; Catherina A Cuevas; Carlos Cespedes; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

3.  Differential effects of maternal nutrient restriction through pregnancy on kidney development and later blood pressure control in the resulting offspring.

Authors:  K A Brennan; S Kaufman; S W Reynolds; B T McCook; G Kan; I Christiaens; M E Symonds; D M Olson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-05-14       Impact factor: 3.619

4.  Corticosteroids induce COX-2 expression in cardiomyocytes: role of glucocorticoid receptor and C/EBP-beta.

Authors:  Haipeng Sun; Elena Sheveleva; Beibei Xu; Hiroyasu Inoue; Tim G Bowden; Qin M Chen
Journal:  Am J Physiol Cell Physiol       Date:  2008-07-23       Impact factor: 4.249

5.  Postnatal regulation of 15-hydroxyprostaglandin dehydrogenase in the rat kidney.

Authors:  Ying Liu; Zhanjun Jia; Ying Sun; Li Zhou; Maicy Downton; Ren Chen; Aihua Zhang; Tianxin Yang
Journal:  Am J Physiol Renal Physiol       Date:  2014-03-19

6.  The efficacy and safety of multiple versus single doses dexamethasone in unicompartmental knee arthroplasty: A protocol of randomized controlled trial.

Authors:  Dehong Gao; Xin Liu; Fan Zhang; Mingyan Ding
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.